| OVERALL PORTFOLIO COMPOSITION (%) | |
| TOP 10 HOLDINGS ( 54.07% OF TOTAL ASSETS) | |
| Company | Symbol | % Assets | | Alexion Pharmaceuticals, Inc. | ALXN | 5.47 | | Celera Corporation | CRA | 5.26 | | Celgene Corporation | CELG | 5.13 | | Cephalon, Inc. | CEPH | 5.69 | | Gilead Sciences, Inc. | GILD | 5.22 | | Human Genome Sciences, Inc. | HGSI | 5.31 | | Life Technologies Corporation | LIFE | 5.5 | | MILLIPORE CP | MIL | 5.3 | | OSI Pharmaceuticals Inc. | OSIP | 5.73 | | Vertex Pharmaceuticals Incorpor | VRTX | 5.46 |
|
| Ratio | FBT | | Average Price/Earnings | 19.78 | | Average Price/Book | 2.31 | | Average Price/Sales | 3.01 | | Average Price/Cashflow | 8.59 |
|
| Sector | | FBT | | Software | | 0 | | Industrial Materials | | 0 | | Energy | | 0 | | Utilities | | 0 | | Hardware | | 5.3 | | Media | | 0 | | Telecommunication | | 0 | | Healthcare | | 94.7 | | Consumer Services | | 0 | | Business Services | | 0 | | Financial Services | | 0 | | Consumer Goods | | 0 |
|
| |
|
0.35% Nasdaq 
Holdings
